2003, Volume 10, Issue 04, pages 241-320
CLINICAL ARTICLE
Br J Cardiol 2003;10:351-7
With an ageing population in the United Kingdom, atrial fibrillation has become an increasing cause of morbidity and mortality, and a burden on health resources....
Read More
CLINICAL ARTICLE
Br J Cardiol 2003;10:329-31
With an ageing population in the United Kingdom, atrial fibrillation has become an increasing cause of morbidity and mortality, and a burden on health resources....
Read More
CLINICAL ARTICLE
Br J Cardiol 2003;10:315-7
In addition to identifying those patients with coronary heart disease, the National Service Frame-work also requires general practitioners to identify all people with a diagnosis...
Read More
CLINICAL ARTICLE
Br J Cardiol 2003;10:310-4
The current focus of our efforts in treating hypertension is to ‘treat to target’ using combination therapy. However, 24-hour control of blood pressure (BP) is...
Read More
CLINICAL ARTICLE
Br J Cardiol 2003;10:308-9
We describe a case of infective endocarditis, which presented with digoxin toxicity. This case is of interest since the patient only became pyrexial six days...
Read More
CLINICAL ARTICLE
Br J Cardiol 2003;10:305-07
Erectile dysfunction (ED) is reported to coexist with cardiovascular disease. It may be the first clinical manifestation of cardiovascular disease making it a helpful, early...
Read More
CLINICAL ARTICLE
Br J Cardiol 2003;10:297-304
Multiple lines of evidence show that high-density lipoproteins (HDL) protect against coronary heart disease (CHD), and that low blood levels of HDL cholesterol (HDLc) indicate...
Read More
CLINICAL ARTICLE
Br J Cardiol 2003;10:293-6
Older patients represent the majority of those considered for coronary intervention but they are under-represented in most clinical trials in this area. Reviewing registry data...
Read More
CLINICAL ARTICLE
Br J Cardiol 2003;10:288-92
Non-steroidal anti-inflammatory drugs (NSAIDs) have potentially dangerous side effects, which has led to intense interest in the development of the cyclo-oxygenase (COX) inhibitors. This article...
Read More
CLINICAL ARTICLE
Br J Cardiol 2003;10:281-6
Epidemiological studies in the Netherlands first demonstrated an inverse relationship between ordinary (technically known as black) tea drinking and cardiovascular disease (CVD) mortality. Subsequent population-based...
Read More
CLINICAL ARTICLE
Br J Cardiol 2003;10:273-80
Coronary heart disease (CHD) is the leading cause of death in the UK. Approximately 50% of myocardial infarctions occur in patients with no prior history...
Read More
NEWS
Br J Cardiol 2003;10:269-71
Cardiac rehabilitation received full support in the
National Service Framework (NSF) for Coronary Heart Disease (CHD)....
Read More
EDITORIAL
Br J Cardiol 2003;10:251-2
The early, non-invasive detection of coronary artery disease is a major challenge confronting contemporary cardiology. In particular, the early identification of vulnerable plaques that may...
Read More